Establishing Consensus on New Treatment Options

By Monty Pal, MD - Last Updated: September 13, 2024

Dr. Monty Pal is excited for the inaugural AUC3 and establishing consensus in-person on new treatment options in urologic cancers.

AUC3 is the inaugural advanced urologic cancer consensus conference, held in Miami, Florida, on January 23-24, 2025. It’s a first-of-its-kind interactive consensus meeting designed to drive decision-making in the gray areas of bladder and kidney cancers.

Capturing the Rapidly Evolving Landscape of Advanced GU Cancers: AUC3

Toni Choueiri, MDAUC3 | October 15, 2024

Dr. Choueiri outlines the importance of experts putting their heads together to decide on how to approach gray areas.

AUC3: A Conference Designed to Drive Consensus

Jonathan Rosenberg, MDAUC3 | October 7, 2024

AUC3 will drive consensus on clinical guidelines that are vague about advanced kidney and bladder cancer treatments.

First-of-Its-Kind Interactive Decision-Making

Toni Choueiri, MDAUC3 | September 20, 2024

Dr. Toni Choueiri looks forward to the interactive aspect of AUC3 for better decision-making in urologic cancers.

Bringing Experts Together to Define Gray Areas of Bladder and Kidney Cancer

Rana McKay, MDAUC3 | September 6, 2024

Drs. McKay and Rosenberg preview AUC3, the inaugural Advanced Urologic Cancer Consensus Conference.

New Conference Aims to Develop Consensus on Kidney, Bladder Cancer Management

Brandon TwyfordAUC3 | August 8, 2024

AUC3 seeks to reshape the landscape of GU cancer management through interdisciplinary dialogue and consensus building.

Establishing Consensus on New Treatment Options

Related Posts